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A variety of soluble mediators produced by lymphocytes (lymphokines) have been 
reported  to  play  an  important  role  in  regulation  of the  immune  response  (1-3). 
Included among the humoral factors that suppress immunologic reactions are: migra- 
tion inhibitory factor (MIF; 4-6), 1 lymphotoxin (7, 8), interferon  (9,  10),  histamine- 
induced  suppressor factor (11),  and soluble immune response suppressor  (SIRS;  12, 
13). We have recently studied the immunoregulatory function of supernates generated 
from concanavalin A  (Con A)-activated human peripheral blood mononuelear cells 
(PBMC) and demonstrated the elaboration of at least two distinct soluble suppressors 
(14,  15).  One  factor,  soluble  immune  suppressor  of T  cell  proliferation  (SISS-T), 
inhibits T  cell proliferative responses to mitogens and antigens, but does not interfere 
with  a  B  cell activity. This mediator has a  molecular weight  of 30,000-45,000,  has 
saccharide binding specificity for N-acetyl-n-glucosamine, and requires monocytes for 
its generation. A second soluble inhibitor found in these supernates, soluble immune 
suppressor  of immunoglobulin  production  (SISS-B),  inhibits  polyclonal  B  cell  im- 
munoglobulin biosynthesis, but not T cell activation. This lymphokine has a molecular 
weight  of 60,000-90,000,  has  saccharide-binding  specificity for  L-rhamnose,  and  is 
produced by T  cells. Because the amounts of these mediators generated in the Con A 
culture supernates are limited, we investigated the possibility that selected cultured T 
cell (CTC) lines may generate these or other important mediators in greater amounts. 
We have identified an interleukin  2-dependent suppressor CTC line that appears to 
produce large quantities  of SISS-B. Pending  final confirmation of identity between 
SISS-B and the soluble suppressor generated by the CTC line, we have designated 
the  CTC  line-derived suppressor  factor CTC-SISS-B. These data  provide evidence 
that T  cell modulation of B cell-immune response may in part be dependent  on the 
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noglobulin production (human); SISS-T, SISS of T cell proliferation (human); SRC, sheep erythrocytes. 
156  THE JOURNAL  OF  EXPERIMENTAL MEDICINE • VOLUME  154, 1981 FLEISHER ET AL.  157 
elaboration of an endogenous lectinlike suppressor factor that  interacts with specific 
glycoprotein or glycolipid receptors. 
Materials  and  Methods 
Pokeweed mitogen  (PWM;  Grand  Island Biological Co.,  Grand  Island, N.  Y.),  purified 
phytohemagglutinin (PHA; Difco Laboratories, Detroit, Mich.), and Con A  (Sigma Chemical 
Co.,  St.  Louis,  Mo.)  were  prepared as stock solutions in  diluent  consisting of RPMI-1640 
(Grand Island Biological Co.) supplemented with penicillin (50 U/ml), streptomycin (50 pg/ 
ml), and L-glutamine (2.0 raM), and stored at -20°C until used. The B95-8 strain of Epstein- 
Barr virus (EBV)  and Nocardia water-soluble mitogen (NWSM) were prepared and used in 
selected cultures as previously described (16,  17). Tetanus toxoid (Massachusetts Department 
of Public  Health)  and  candida  antigen  (Hollister-Stier, Spokane,  Wash.)  were  extensively 
dialyzed against diluent before use and stored as stock solutions at 4°C. L-rhamnose, N-acetyl- 
v-glucosamine (NAG), L-fucose, and D-galactose (all from Sigma Chemical Co.) were prepared 
as 250-mM stock solutions in diluent and stored at 4°C until used. 
Purification of Human PMBC.  PBMC were isolated from heparinized venous blood of healthy 
adult  volunteer  donors  using  a  modification  of the  method  of B6yum  (18)  as  previously 
described (14). PBMC to be used in the assay of in vitro Ig biosynthesis were washed four times 
over heat-inactivated (56°C  for  30  rain)  fetal calf serum  (FCS;  Reheis,  Phoenix,  Ariz.)  to 
remove detectable human serum proteins. The PBMC were suspended in diluent supplemented 
with 10% (vol:vol) heat-inactivated FCS from selected lots previously screened for support of in 
vitro Ig production. In selected experiments, PBMC were further fractionated to prepare highly 
purified B cells and T cells as previously described (19). Briefly, B cells were isolated by elution 
of cells retained on  immunoabsorbent  columns  composed of rabbit  anti-human  F(ab')2 Ig 
insolubilized with cyanogen bromide to Sephadex G-200 beads (Pharmacia Fine Chemicals, 
Div. of Pharmacia Inc., Piscataway, N.J.) and further purified using an erythrocyte (E)-rosette 
depletion step. T  cells were isolated by collection of the cells not retained by the immunoab- 
sorbent column, followed by a  single E-rosette procedure. Using these techniques, the B cells 
routinely fail to produce measurable Ig in vitro after PWM stimulation (unless T  cells are 
added back). 
Culture of T  Cells with  Conditioned Medium.  T  cells derived from the peripheral blood of a 
patient with a  nonleukemic form of mycosis fungoides were cultured in medium containing 
20%  FCS  (vol:vol). To  promote  continuous  growth  of T  cells,  the  culture  medium  was 
supplemented with 20% (vol:vol) concentrated conditioned medium (produced by cocuhuring 
mononuclear cells from  10 donors with PHA; Associated Biomedic Systems, Inc., Buffalo, N. 
Y.)  to  provide  a  source  of interleukin  2  as  previously described  (20,  21).  When  the  cell 
6  fi  5  concentration reached ~1 ×  10  cells/ml, the cells were diluted to 2.0 ×  10 -3.0 ×  10  cells/ml 
using  fresh  conditioned  medium  as  above.  More  than  90%  of the  cultured  cells  formed 
spontaneous E-rosettes on periodic testing and cell viability was routinely in excess of 90% as 
measured by supravital dye exclusion (22). 
Generation of CTC-SISS-B.  Suppressive supernates were generated by washing the CTC cells 
(obtained at the time of feeding) five times to remove interleukin 2, PHA, and other agents, 
and then culturing these washed cells (1 ×  10  ~) in the absence of conditioned medium for 8-24 
h in a humidified atmosphere containing 5% CO2. At the conclusion of the culture period, the 
supernates were recovered and contaminating cells were removed by filtration through 0.45-# 
membranes  (Millipore Corp., Bedford, Mass.)  before storage at  -20 and -80°C  until used. 
The viability of the T  cells elaborating the supernates was the same as that found at the time 
of feeding (generally >90%). 
Reverse Hemolytic Plaque Assay.  The technique of coupling protein A  (Staphylococcus aureus; 
Pharmacia Fine Chemicals) to sheep erythrocytes (SRC), the preparation and the characteri- 
zation of the rabbit antisera to human Ig (IgG, IgA, and IgM), and the method for plaquing 
are as previously described (23,  24).  Briefly, 2 million PBMC suspended in  1 ml of medium 
were cultured in 5-ml tubes (2058;  Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, 
Calif.) in the presence and absence of PWM for 6-7 d under the identical culture conditions as 
above. At the end of the culture period, the cells were washed four times and suspended in 1 ml 
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of 1.12% Seaplaque agarose (Marine Colloids Inc., Springfield, N. J.), followed by the addition 
of 0.025  ml of 30%  protein A-SRC. The contents of the tubes were then swirled over Petri 
dishes previously coated with 4 ml of 2.5% agarose. The agarose-cell mixture was allowed to 
solidify, followed by the addition of 1 ml of appropriately diluted rabbit anti-human Ig, and 
incubation for 1 h at 37°C in a humidified CO~ incubator. Plaque formation was initiated by 
the  addition  of  1  ml  of a  1:8  dilution  of SRC-absorbed  guinea  pig  complement  (Flow 
Laboratories Inc., Rockville, Md.) and an additional 2-h incubation at 37°C. After this, the 
plates were  aspirated ~.a~d held  overnight  at  4°C.  The  number  of plaques  present  in  the 
duplicate dishes were enumerated using an automated video plaque counter (Optimax Inc., 
Hollis, N. H.). The data obtained are expressed as the number of Ig-seereting cells per euhure. 
Assay of Ig Biosynthesis.  The techniques of the culture system for in vitro Ig biosynthesis and 
the methods for the radioimmunoassay (RIA) determinations of IgG, IgA, and IgM have been 
previously described (19, 25). Briefly, 2 million PBMC or 5 ×  l0  s highly purified B cells (in the 
absence and presence of autologous T  cells) were cultured in loosely capped 1-dram vials with 
a polyclonal activator for 12 d in 1 ml of culture medium under identical culture conditions as 
above. The polyclonal activators used included PWM, EBV, and NWSM. At the termination 
of the culture period, the supernates were collected and the amounts of IgG, IgA, and IgM 
synthesized and secreted into the medium were determined by heavy chain-specific, double- 
antibody RIA (25, 26). 
Lymphocyte Proliferation.  200,000 lymphoeytes suspended in 0.2 ml of medium were cultured 
in microtiter plates (Falcon Labware) in the presence and absence of the mitogenic lectins PHA 
(1:2,000 final dilution), Con A  (20 #g/ml), or PWM (10 #g/ml) for 3 d, or the recall antigens 
tetanus toxoid (2.5 Lf/ml) or candida (0.25%)  for 6 d at 37°C in a humidified CO2 incubator. 
5 h before the conclusion of culture, 1.0 #Ci of [SH]methyl-thymidine (New England Nuclear, 
Boston, Mass.;  25  Ci/ml spac)  was added to each microtiter well. Cells were subsequently 
harvested onto fiberglass filters using a multiple-channel automated cell harvester and washed 
repeatedly with distilled water. Cell-associated radioactivity was determined by transfer of the 
filters to  the  glass vials containing  7.5  ml  of seintillant  (Uhrafluor,  National  Diagnostics, 
Sommerville, N. J.) and counting in an automated counter (Beckman Instruments Inc.). 
Allosensitization of PBMC.  Allosensitization of PBMC was performed as prevously described 
(27). Briefly, fresh PBMC and irradiated (2,000  rad) PBMC were suspended at  1 ×  106 cells/ 
ml in medium supplemented with 5% human plasma, 4 ml of each population were added to 
flasks (3013;  Falcon Labware), and cultured under identical conditions as described above. 
Additional cultures of nonirradiated stimulator cells to be used as targets were established at 
this time, and PHA (1:200)  was added to these cultures 72 h before the cytotoxicity assay. On 
the seventh day, the cells were harvested for the cytotoxicity assay. In addition, triplicate 0.2- 
ml aliquots of cells were pulsed with 1.0 #Ci [SH]methyl-thymidine in microtiter plates (Falcon 
Labware) and evaluated as above to quantitate allogeneic cell-induced proliferation (mixed 
lymphocyte reaction [MLR]). 
Cytotoxicity Assay.  On the day of assay, the target cells were suspended in 0.6 ml in culture 
medium  containing  200  #Ci  of 51Cr sodium  chromate  (300  mCi/mg;  Amersham  Corp., 
Arlington Heights, Ill.) for 90 min at 37°C with frequent shaking. The labeled cells were then 
washed and suspended at  1 ×  105 cells/ml. Triplicate cultures of putative effector cells and 
target cells were established by adding 0.1  ml of each cell suspension to the wells of round- 
bottomed microtiter plates (Linbro Chemical Co.,  Hamden,  Conn.).  Control  measurements 
consisted of target cells incubated with medium alone or with 5% Triton X  (Research Products 
International Corp., Elk Grove Village, Ill.). The plates were centrifuged at 50 g  for 2 min, 
incubated at  37°C  for 6  h,  and  recentrifuged at  400 g  for 5  min,  and  the supernates were 
harvested and counted in a gamma counter (Beckman Instruments Inc.). Percent specific lysis 
was calculated by the following formula: 
(cpm experimental -  cpm media control) 
Percent specific lysis =  100 × 
(cpm detergent -  cpm media control) 
Chromium release from the media control was always <20% of the detergent control. Effector 
cell activity was tested at four different effector:target (E:T) ratios ranging from 40:1  to 0.6:1. FLEISHER  ET  AL.  159 
Results 
Characteristics of the Human CTC Line.  The CTC line that produces the mediator 
CTC-SISS-B requires the presence of conditioned medium containing interleukin 2 
for maintenance. Furthermore, in previous studies we have shown that this CTC line 
functions as  a  potent  suppressor  cell  for PWM-induced  in  vitro  immunoglobulin 
production (21). Evaluation of the phenotype of this T cell line with the fluorescence- 
activated cell sorter II system (Becton, Dickinson & Co.) demonstrated that the cells 
were reactive with monoclonal antibodies to OKT3  (Ortho Pharmaceutical Corp., 
Raritan, N. J.), Tac  (an antigen on  activated T  cells;  28),  and Ia-like  (DA-2;  29) 
antigens. The phenotypic characteristics and the cell-mediated suppressor activity of 
this CTC have remained constant throughout the investigations described below. 
CTC-SISS-B  Production by  the  CTC  Line.  The  addition of supernates  containing 
CTC-SISS-B to cultures of human PBMC stimulated with PWM resulted in a dose- 
related suppression of polyclonal Ig production measured by the reverse hemolytic 
plaque  assay as  shown  in  Fig.  1.  There  is  no  evidence of class  specificity in  the 
inhibitory activity of CTC-SISS-B as demonstrated by the equivalent suppression of 
IgG, IgA, and IgM production observed when the supernate was added to PWM- 
stimulated cultures at final concentrations of 1:10 (Fig. 2),  1:50, and 1:250  (data not 
shown). Furthermore, the addition of CTC-SISS-B at a final concentration of 1:10 to 
cultures of human PBMC stimulated with the T  helper cell-independent polyclonal 
activator EBV resulted in >80% inhibition of IgG, IgA, and IgM biosynthesis (data 
not shown). Thus,  the suppression  by this mediator is  neither isotype specific nor 
dependent on the presence of PWM in the culture system. 
Specificity  of CTC-SISS-B  Suppression.  The  inhibition  mediated  by  CTC-SISS-B 
appeared  to be specific for Ig production. The addition of this mediator to T  cell 
proliferative assays stimulated either with mitogens, antigens, or allogeneic cells had 
no suppressive  effect on  the  incorporation of tritiated  thymidine by  these T  cells 
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Fro.  1.  CTC-SISS-B dose-response  relationship for suppression  of PWM-induced Ig production. 
Inhibition by varying dilutions of CTC-SISS-B  is expressed as the mean percent suppression of the 
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FIG. 2.  CTC-SISS-B suppresses equivalently  the production  of IgG, IgA, and IgM after PWM 
stimulation. Inhibition of the total amount of IgG, IgA, and IgM secreted into the culture medium 
by CTC-SISS-B (1:10) is expressed as the mean  percent suppression for each specific class of Ig 
produced in a 12-d culture stimulated with PWM. Error bars represent the SEM. 
TABLE  I 
Effect of CTC-SISS-B  Addition on T Cell Proliferation to Mitogens (3-d 
Culture), Antigens (6-d Culture), and Allogenic Cells (7-d Culture) 
Activator 
[3H]methyl-thymidine 
incorporation(cpm  ± SEM) 
CTC-SISS-B  Medium  (1:10) 
RPMI-1640  513 + 44  754 ± 66 
PHA  27,639 ± 288  43,933 ± 5,542 
Con A  79,304 ± 6,432  82,706  ± 2,784 
PWM  62,486 ± 2,981  62,694  ± 3,763 
Caodida  33,289 ±  1,480  34,278  ± 4,571 
Tetanus  34,995 ± 2,994  37,213  ±  1,546 
Allogeneic cells (MLR)  34,995 ±  1,383  47,009  ± 3,314 
(Table I). Furthermore, no inhibition of 5XCr release was observed by the addition of 
CTC-SISS-B  during  either  the  sensitization  or  effector  phase  in  assays  of T  cell- 
mediated allogeneic lympholysis (Table II), These experiments were performed with 
the supernate  at  final dilutions of 1:4 and  1:10  in these assays, concentrations  that 
consistently  produced  >80%  suppression  of Ig biosynthesis.  Direct  addition  of the 
supernates to either PBMC  or purified T  cells at  final dilutions of 1:4 and  1:10 did 
not result in tritiated thymidine incorporation above background; thus there appears 
to be little possibility that PHA carryover from the conditioned medium has any role 
in the observed suppression of Ig production by this mediator. 
Noncytotoxic Mechanism  of CTC-SISS-B Suppression.  The effect of delayed addition of 
CTC-SISS-B  on  PWM-induced  Ig production  is  shown  in  Fig.  3.  Addition of the 
supernates after the initial 24-48 h of the 7-d culture period had little or no suppressive 
effect  on  the  subsequent  Ig biosynthesis  (five of six  experiments).  Furthermore,  as 
shown in Fig. 4, CTC-SISS-B addition did not affect the number of Ig-secreting cells 
that appear early during the PWM-stimulated culture (3-4 d), but produced marked 
suppression of Ig production during the period of maximal response  (5-7  d). These 
data provide evidence that CTC-SISS-B acts through interference with differentiation FLEISHER  ET  AL. 
TABLE  II 




Percent SlCr release (mean ±  SEM) 
Medium  CTC-SISS-B (1 : 10) 
40:1  28.2  ±  3.4  32.9 +  2.7 
10:1  19.3 ±  3.9  25.0 ±  2.3 
2.5:1  9.6 ±  2.2  15.7 ±  1.9 
0.6:1  6.0 ±  1.9  9.9 ±  2.1 
Percent SlCr release (mean ±  SEM) 
Experiment 2 
E:T  Medium  CTC-SISS-B (1 : 10) 
10:1  44.8 ±  4.8  42.9 +  5.2 
In experiment 1, CTC-SISS-B was added during the allosensitization (gener- 
ation) phase. In experiment 2,  CTC-SISS-B was added during the cytotoxic 
effector phase. 
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Fla.  3.  Late addition of CTC-SISS-B. A representative experiment of the inhibition of Ig produc- 
tion observed after addition of CTC-SISS-B  (1:10)  at  various times during the PWM-stimulated 
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Flo.  4.  Time-course of PWM-induced Ig production. A representative experiment comparing the 
time course of PWM-induced Ig production in the presence and absence of CTC-SISS-B (1:10)  is 
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of the B  lymphocytes into Ig-secreting cells rather than via a  mechanism of direct 
cytotoxicity. Furthermore, the absence of augmented 51Cr release from labeled lym- 
phocytes in the presence of this mediator is additional evidence against  a  cytotoxic 
mechanism of action for CTC-SISS-B. 
Target of CTC-SISS-B  Suppression.  The cellular site of CTC-SISS-B activity was 
evaluated with experiments in which the supernate was added to T-depleted PBMC 
(B cells) stimulated by the T helper cell-independent activator, EBV. As seen in Table 
III, there was equivalent suppression of Ig production whether T  cells were absent or 
present with the B cells and monocytes in these cultures. Similar results were obtained 
using  the  activator NWSM  as  the T-independent  polycolonal activator  (data  not 
shown). Thus, CTC-SISS-B does not appear to act via a regulatory T  cell, but rather 
suppresses  Ig  biosynthesis  either  by  direct  action  on  the  B  cell  or,  alternatively, 
through an action on monocytes as has been described for SIRS (13). 
Sugar Specificity of CTC-SISS-B.  As seen in Fig.  5, the inhibitory effects of CTC- 
SISS-B were largely abrogated in the presence of the simple sugar  L-rhamnose (25 
raM).  In  contrast,  the  addition  of 25  mM  NAG  had  no  effect on  CTC-SISS-B- 
mediated suppression, whereas the addition of equimolar concentrations of L-fucose 
TAnLE III 
Effect of CTC-SISS-B ( l :  l O Final Concentration) Addition on EB V-induced 
Ig Biosynthesis 
IgG  IgA  IgM 
B cells 
B cells +  PWM 
B cells +  EBV 
B cells +  EBV +  CTC-SISS-B 
B +  T  cells 
B +  T  cells +  EBV 
B +  T  cells +  EBV +  CTC-SISS-B 
ng/ml 
<6  <26  < 17 
<6  <26  < 17 
69  633  1,288 
<6  62  115 
<6  <26  < 17 
113  734  1,393 
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Fro.  5.  Specific saccharide blockade of CTC-SISS-B suppression of PWM-induced Ig production. 
Mean number of Ig-secreting cells after PWM stimulation in the presence of CTC-SISS-B (1:250) 
with specific saccharides (25 mM) added at the initiation of the culture. Error bars represent the 
SEM. FLEISHER  ET  AL.  163 
and  D-galactose  resulted  in  a  modest  decrease  in  the  observed  inhibition  of Ig 
production (40% suppression in cultures with these monosaccharides vs. 60% inhibition 
without). In all these experiments, CTC-SISS-B was used at a  final concentration of 
1:250 because this was judged to be the most appropriate area on the dilution curve 
(Fig.  1)  to  evaluate  saccharide  blockade  of the  action  of this  suppressor.  Sugar 
concentrations used in these experiments did not result in significant suppression of 
PWM- or EBV-induced Ig production. Preliminary studies suggest that CTC-SISS-B 
is also retained on columns composed of L-rhamnose immobilized on agarose bead 
supports. 
Kinetics and Radiostnsitivity of CTC-SISS-B Elaboration.  CTC-SISS-B is present in the 
cell-free supernate  within  8  h  of culture  of the  washed  CTC  (in  the  absence  of 
interleukin 2-containing medium). The elaboration of CTC-SISS-B is partially serum 
dependent in that generation of the supernate in the absence of FCS results in less 
suppressor activity (Table IV, part 1). Furthermore, the cells producing this mediator 
are  relatively radioresistant  in  that  500 or 2,000 rad irradiation  after the washing 
procedure did not interfere with the elaboration of CTC-SISS-B (Table IV, part 2). 
Physico-Chernical Characteristics of CTC-SISS-B.  A  Sephadex G-100 molecular sieve 
chromatographic profile of CTC-SISS-B  is  shown  in  Fig.  6.  Inhibitory activity  is 
clearly  present  as  a  peak  in  the  molecular  weight  range  of 60,000-90,000.  This 
TABLE  IV 
CTC-SISS-B Generation Is Enhanced by the Presence of Serum in the Culture 
and Is Resistant to At Least 2,000 Rad of lrradiation 
Mean percent suppres- 
sion Ig production + 
SEM 
1  CTC-SISS-B (1:4):  10% FCS  85.3 +  3.7 
CTC-SISS-B (1:4):  no serum  38.3 +  19.3 
2  CTC-SISS-B (1:10): no irradiation  83.6 +  3.2 
CTC-SISS-B (1:10): 500 rad  59.5 +  31 
CTC-SISS-B (1:10): 2,000 rad  60.0 +  28 
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FIG.  6.  Molecular  sieve chromatography  of CTC-SISS-B.  CTC-SISS-B  was  fractionated  on  a 
Sephadex  G-100  column  prepared  in  phosphate  buffer  (pH  7.4).  Fractions  eluted  from  the 
chromatographic gel were tested for suppressor activity (0)  in the PWM-stimulated culture with 
the results expressed as the percent  suppression of the expected  number of Ig-secreting cells per 
culture. Protein concentration is indicated by the percent absorbance at 280 nm (O) for the applied 
supernate and the elution profile for the calibration proteins used are indicated by the arrows. 164  PRODUCTION  OF  A  SOLUBLE  SUPPRESSOR  OF  HUMAN  B  CELL  Ig 
corresponds to the molecular weight range observed in similar studies of suppressor 
supernates from Con A-activated human PBMC  (15).  Furthermore, CTC-SISS-B is 
acid stable but partially heat labile at 56°C  (data not shown), which also correlates 
with the physico-chemical properties of Con A-generated SISS-B (15). 
Discussion 
In this paper we present  data  characterizing  a  lectinlike  soluble suppressor of Ig 
production that is generated by a  cultured human T  suppressor line. This mediator 
appears to be identical  to SISS-B produced by Con A-activated peripheral blood T 
cells. The inhibitory mechanism of this mediator does not involve cell cytotoxicity, as 
indicated by the lack of inhibition after late addition of the supernate, the failure of 
CTC-SISS-B to alter early Ig biosynthesis after PWM  stimulation  (at 3 and 4  d  of 
culture) and the lack of effect on ~aCr release. Furthermore, the suppression observed 
is not due to PHA carry-over from the conditioned medium as evidenced by:  (a) the 
failure of PBMC or purified T  cells to proliferate in response to the supernate, (b) the 
observed inhibition of Ig production at high dilutions  (1:1,250)  of the supernate,  (c) 
the  demonstration  that  the  suppressor  activity  has  a  molecular weight  of 60,000- 
90,000, and (d) the blockade of mediator-induced suppression by L-rhamnose. 
The lectinlike characteristics of CTC-SISS-B are demonstrated by the reversal of 
suppression with addition of the simple sugar L-rhamnose. This reversal appears to be 
relatively specific in that other saccharides, including NAG, L-fucose, and D-galactose, 
had little or no effect on the suppression of Ig production.  Because L-rhamnose is not 
found  in  mammalian  cells,  it  is  likely  that  this  saccharide  closely  resembles  a 
saccharide  constituent  of the glycoprotein or glycolipid surface receptor that  CTC- 
SISS-B interacts  with.  We  are currently  screening other oligosacchardes  to  further 
define this interaction. CTC-SISS-B suppresses Ig production in cultures of T-depleted 
PBMC stimulated with the T-independent activator EBV, indicating that the media- 
tor SISS-B acts either directly on the B cell or via action on the monocyte. Irradiation 
of the CTC with  500  or 2,000  rad does not  interfere with the elaboration of CTC- 
SISS-B.  Furthermore,  elaboration  of the  supernate  occurs within  8-16  h  after the 
initiation of the culture, and generation of CTC-SISS-B is partially serum dependent 
in that more suppressor activity is found in supernates produced  in the presence of 
serum.  The  molecular weight,  saccharide  specificity, site  and  mode of action,  and 
generation characteristics of CTC-SISS-B are the same as those we have previously 
described for SISS-B generated from Con A-activated PBMC  (15).  Thus, it appears 
likely that  these  two  supernates  contain  the  same suppressor  factor.  Based  on  the 
dilution curves, it appears that the CTC line is enriched for the cells producing this 
factor in  that  there  is  ~50-100-fold  more suppressor activity in  the CTC  (1  ×  106 
cells/ml) supernate than in the Con A-activated PBMC (2.5 x  106 cells/ml) supernate. 
CTC-SISS-B  has  certain  characteristics  that  identify  differences  between  this 
mediator and  other  humoral  suppressors found  in  the  supernates  of lymphoid cell 
lines. For example, although MIF is blocked by L-rhamnose (30), it differs from CTC- 
SISS-B based on the reported molecular weight for MIF of the  17,000-25,000  mol wt 
(31).  Human lymphotoxins also differ from CTC-SISS-B based on molecular weight 
as well as in terms of their cytotoxic mode of action  (32). 
Interferon has been described to inhibit  specific antibody production  in both the 
murine model and man  (9,  10)  as well as having been implicated  as a  mediator of FLEISHER ET AL.  165 
Con  A-activated suppression  of proliferative responses in  man  (33).  Studies  in  our 
laboratory have demonstrated that lymphoblastoid-derived interferon (human alpha 
interferon)  inhibits PWM-induced  Ig biosynthesis, z However, we have not observed 
reversal of the interferon-mediated suppression by L-rhamnose (T. A. Fleisher and W. 
C. Greene, unpublished data). Thus, it does not appear that CTC-SISS-B suppression 
results  from  interferon  activity.  Finally,  because  CTC-SISS-B  has  no  effect  on 
proliferative responses to either mitogens or antigens by either PBMC or T  cells, it is 
unlikely that the supernate contains either the lymphocyte-stimulating or -inhibiting 
factors (34). 
These data suggest that a  long-term-cultured human T  suppressor cell elaborates 
the  same  humoral  suppressor  factor  as  is  generated  by  Con  A-activated  human 
PBMC. Furthermore, this mediator specifically modulates B cell Ig production in the 
absence of T  cells via recognition  and binding to defined carbohydrate-containing 
surface receptors. 
Summary 
A  human  suppressor  T  cell  maintained  in  long-term  culture  with  conditioned 
medium  containing  interleukin  2  elaborates  a  suppressor  factor(s)  that  specifically 
inhibits human polyclonal B cell immunoglobulin biosynthesis. This soluble immune 
suppressor supernate of immunoglobulin production (CTC-SISS-B) shares a number 
of features with the previously described suppressive mediator elaborated by concan- 
avalin A-activated human peripheral T  cells (SISS-B) including:  (a) the inhibition by 
a noncytotoxic mechanism, (b) the suppression of immunoglobulin biosynthesis either 
through direct action on the B cell or indirect action via the monocyte, (c) the loss of 
inhibition in the presence of the monosaccharide L-rhamnose, (at) the elaboration by 
cells irradiated  with  500  or 2,000  rad,  and  (e)  molecular weights  of 60,000-90,000. 
Furthermore,  the  suppression  by  this  mediator  appears  to  be  specific  for  B  cell 
immunoglobulin production in that CTC-SISS-B has no effect on T  cell proliferation 
to mitogens, antigens, and allogeneic cells or on T  cell-mediated cytotoxicity. These 
data indicate that one possible mechanism of suppressor T  cell inhibition of human 
immunoglobulin production is via the generation ofa lectinlike suppressor lymphokine 
that interacts with defined saccharide determinants on the cell surface of either the B 
cell or monocyte. 
Received  for publication 3 March  1981 and in revised  form  13 April 1981. 
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